Marietta A. Weber, et.al., Endogenous leukemia inhibitory factor attenuates endotoxin response., Laboratory investigation; a journal of technical methods and pathology, 2005, 85

http://rdf.ncbi.nlm.nih.gov/pubmed/15702085

Marietta A. Weber, et.al., Endogenous leukemia inhibitory factor attenuates endotoxin response., Laboratory investigation; a journal of technical methods and pathology, 2005, 85

pubmed

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal circulating serum amyloid protein level_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0010214I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• abnormal hepatocyte morphology_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0000607I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• hepatic necrosis_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0001654I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• liver hemorrhage_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0003888I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• abnormal pilomotor reflex_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0001492I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• increased circulating alanine transaminase level_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0002941I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• increased circulating interleukin-6 level_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0008596I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• decreased leukocyte cell number_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0000221I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• decreased interleukin-10 secretion_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0008661I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• increased circulating aspartate transaminase level_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0005343I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• tremors_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0000745I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• increased susceptibility to bacterial infection induced morbidity/mortality_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0009788I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• diarrhea_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0005036I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• increased susceptibility to endotoxin shock_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0008735I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• increased susceptibility to weight loss_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0010180I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• thrombocytopenia_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0003179I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• liver vascular congestion_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0010019I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw
• increased circulating tumor necrosis factor level_Lif<tm1Stw>/Lif<tm1Stw>
  http://metadb.riken.jp/0008553I129S1SvBALBcLiftm1StwLiftm1StwLiftm1Stw